|

Cenerimod Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Also known as: ACT-334441

Pipeline

Phase 3: 1

Top Sponsors

  • Viatris Innovation GmbH1

Indications

  • Nephritis, Lupus1
  • Lupus Erythematosus, Systemic1
  • Lupus1

Kissimmee, Florida1 trial

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

Alloy Clinical Research LLC

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.